Skip to main content
Breast Cancer : Targets and Therapy logoLink to Breast Cancer : Targets and Therapy
. 2018 Mar 16;10:51. doi: 10.2147/BCTT.S166117

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]

PMCID: PMC5858826  PMID: 29589598

Criscitiello C, Viale G, Curigliano G, et al. Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date. Breast Cancer (Dove Med Press). 2018;10:23–29.

On page 23, Giuseppe Curigliano’s affiliation was incorrcectly listed as European Institute of Oncology, Milan, Italy. It should be Department of Oncology and Hemato-Oncology, Division of Early Drug Development for Innovative Therapy, University of Milan, European Institute of Oncology, Milan, Italy.


Articles from Breast Cancer : Targets and Therapy are provided here courtesy of Dove Press

RESOURCES